Short Term Wearable Defibrillator
DeviceShort-term Wearable Defibrillator (SWD 1000)
NCT Number: NCT02188147
The purpose of this study is to conduct an observational investigation of a novel care path used to manage emergency department (ED) presenting syncope patients on an outpatient basis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Danbury, Connecticut, United States
OBJECTIVES To conduct a prospective observational study assessing a unique outpatient care model in which syncope patients are provided with, and trained to use, a wearable defibrillator prior to discharge from the emergency department (ED). Observational data will be collected to assess the logistics of equipping patients with the device and providing training in the ED, and the ability of patients to receive follow-up care on an outpatient basis. In addition, data will be collected to confirm that the device meets expected safety. The experience gained from this stage of the study will be used to guide future studies of device's functionality enhancements and definitive device safety and efficacy.
STUDY POPULATION Participants will be patients presenting to the ED following a syncope event which has been defined as cardiac, or potentially cardiac, i.e. undiagnosed in nature.
INTERVENTION A wearable defibrillator optimized for short-term ambulatory use with adhesive electrodes will be prescribed for up to 14 days of use following emergency department discharge or until the physician responsible for the subject's care defines an alternative treatment plan.
STUDY DESIGN This is a single-arm feasibility study.
STUDY SIZE The study will enroll a minimum of 50 and a maximum of 80 subjects. A maximum of 20 centers will be used for enrollment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A. ED workup indicates that the patient may have experienced syncope that is cardiac in nature (any one or more of the following apply:
Exclusion criteria
Short-term Wearable Defibrillator (SWD 1000)
Time frame: enrollment to 30 days
% time the device detected noise on both leads at the same time.
Time frame: enrollment to 30 days
% time that the device is monitoring using only one lead due to noise detected on the other lead
Time frame: enrollment to 30 days
Followup care for syncope - outpatient medical care visits
Time frame: enrollment to 30 days
Followup care for syncope - returned to ER or admitted to hospital
Time frame: enrollment to 30 days
Average time the SWD 1000 was used by participants
Zoll Medical Corporation
Industry
Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study Protocol
Acronym: ASAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05571254
Consciousness Disorders, Disease Attributes
Durrës, Albania
View Trial DetailsNCT01003262
Consciousness Disorders, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT03803215
Cardiovascular Diseases, Consciousness Disorders
Lavagna, Italy
View Trial DetailsNCT03487237
Cardiovascular Diseases, Consciousness Disorders
Paris, France
View Trial Details